BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7485941)

  • 1. A comparison of the efficacy of dopexamine and dobutamine for increasing oxygen delivery in high-risk surgical patients.
    Boyd O; Lamb G; Mackay CJ; Grounds RM; Bennett ED
    Anaesth Intensive Care; 1995 Aug; 23(4):478-84. PubMed ID: 7485941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Goal-directed therapy with dopexamine, dobutamine, and volume expansion: effects of systemic oxygen transport on hepatic ultrastructure in porcine sepsis.
    Tighe D; Moss R; Heywood G; al-Saady N; Webb A; Bennett D
    Crit Care Med; 1995 Dec; 23(12):1997-2007. PubMed ID: 7497722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of clonidine, dopamine, dobutamine, and dopexamine on basal and acid-stimulated mucosal blood flow in the rat stomach.
    Holzer P; Painsipp E
    Crit Care Med; 2001 Feb; 29(2):335-43. PubMed ID: 11246314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE; Arlt A; Meissner A; Lins M
    Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting.
    MacGregor DA; Butterworth JF; Zaloga CP; Prielipp RC; James R; Royster RL
    Chest; 1994 Sep; 106(3):835-41. PubMed ID: 7915979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension.
    Hachenberg T; Möllhoff T; Holst D; Hammel D; Brüssel T
    J Cardiothorac Vasc Anesth; 1997 Jun; 11(4):453-7. PubMed ID: 9187994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged infusion of varied doses of dopexamine hydrochloride for low cardiac output after cardiac surgery.
    Santman FW
    J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):568-72. PubMed ID: 1358247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P; Xenikakis T; Linardakis M; Hassoulas J
    Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of dopexamine HCl in conscious and halothane-anaesthetised horses.
    Muir WW
    Equine Vet J Suppl; 1992 Feb; (11):24-9. PubMed ID: 9109955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dobutamine and dopexamine on hepatic micro- and macrocirculation during experimental endotoxemia: an intravital microscopic study in the rat.
    Secchi A; Ortanderl JM; Schmidt W; Walther A; Gebhard MM; Martin E; Schmidt H
    Crit Care Med; 2001 Mar; 29(3):597-600. PubMed ID: 11373427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE; Arlt A; Meissner A; Lins M
    Eur J Med Res; 2008 Oct; 13(10):459-63. PubMed ID: 19008172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative vasoactive therapy for heart failure.
    Benotti JR; McCue JE; Alpert JS
    Am J Cardiol; 1985 Jul; 56(3):19B-24B. PubMed ID: 4025154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopexamine increases splanchnic blood flow but decreases gastric mucosal pH in severe septic patients treated with dobutamine.
    Meier-Hellmann A; Bredle DL; Specht M; Hannemann L; Reinhart K
    Crit Care Med; 1999 Oct; 27(10):2166-71. PubMed ID: 10548200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock.
    Levy B; Nace L; Bollaert PE; Dousset B; Mallie JP; Larcan A
    Intensive Care Med; 1999 Sep; 25(9):942-8. PubMed ID: 10501749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for the treatment of patients with septic shock.
    Meier-Hellmann A; Reinhart K
    Acta Anaesthesiol Scand Suppl; 1997; 111():177-80. PubMed ID: 9421002
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancing liver blood flow after cardiopulmonary bypass: the effects of dopamine and dopexamine.
    Sharpe DA; Mitchel IM; Kay EA; McGoldrick JP; Munsch CM; Kay PH
    Perfusion; 1999 Jan; 14(1):29-36. PubMed ID: 10074644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of dopamine, dopexamine, and dobutamine on jejunal mucosal perfusion early after cardiac surgery.
    Thorén A; Elam M; Ricksten SE
    Crit Care Med; 2000 Jul; 28(7):2338-43. PubMed ID: 10921562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenic potential of dopexamine hydrochloride during halothane anaesthesia in dogs.
    Neustein SM; Dimich I; Sampson I; Sadeghi A; Mezrow C; Shiang H
    Can J Anaesth; 1994 Jun; 41(6):542-6. PubMed ID: 7915210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive heart failure.
    Tan LB; Littler WA; Murray RG
    Int J Cardiol; 1991 Feb; 30(2):203-8. PubMed ID: 2010243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.